|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/04 | |
| A61K 31/519 | |||
| A61P 35/00 |
| (11) | Patento numeris | 3431475 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18186675.7 |
| Europos patento paraiškos padavimo data | 2014-02-08 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-01-23 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201361767761 P | 2013-02-21 | US |
| (72) |
CHEKAL, Brian Patrick, US
IDE, Nathan D., US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
|
| (54) | SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR |
| SOLID FORMS OF A SELECTIVE CDK4/6 INHIBITOR |